| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016143 |
| Receipt No. | R000018740 |
| Official scientific title of the study | Evaluation of EGJ (esophagogastric junction) function using elastography |
| Date of disclosure of the study information | 2015/04/01 |
| Last modified on | 2019/01/10 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Evaluation of EGJ (esophagogastric junction) function using elastography | |
| Title of the study (Brief title) | Evaluation of EGJ (esophagogastric junction) function using elastography | |
| Region |
|
|
| Condition | |||
| Condition | Gastroesophageal Reflux Disease,functional dyspepsia | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To explore the possibility of esophageal function evaluation by abdominal ultrasonography (US). To examine the usefulness of US in esophageal function evaluation. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To reveal the potential evaluation of organic and functional disorders of the esophagogastric junction by abdominal ultrasound elastography |
| Key secondary outcomes | To verify whether can be evaluated by abdominal ultrasound elastography a therapeutic effect in post-treatment |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Case performed upper gastrointestinal endoscopy and abdominal ultrasonography
Performance Status 0-2 |
|||
| Key exclusion criteria | Case can't keeping in supine state
Case having severe complications or severe mental disorder |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshiki Hirooka |
| Organization | Nagoya University Hospital |
| Division name | Department of Endoscopy |
| Address | 65 Tsuruma-cho, Showa-ku, Nagoya, Japan |
| TEL | +81-52-744-2602 |
| hirooka@med.nagoya-u.ac.jp | |
| Public contact | |
| Name of contact person | Suhara Hiroki |
| Organization | Nagoya University Graduate School of Medicine |
| Division name | Gastroenterology and Hepatology |
| Address | 65 Tsuruma-cho, Showa-ku, Nagoya, Japan |
| TEL | +81-52-744-2602 |
| Homepage URL | |
| h-suhara@med.nagoya-u.ac.jp | |
| Sponsor | |
| Institute | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 名古屋大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | The number of CS as determined by US-EG in 30s was significantly lower in the RE group as compared with the non-RE group 6.0(5.5-6.7) vs 8.6 (6.6-10.0) p>0.00001. |
| Other related information | The esophagogastric junction using elastography based subcutaneous fat and liver consider the dfference and the ratio in hardness. Change of hardness in each diseases records shape, space and frequency of the waveform prospectively. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018740 |